Dividend
-
-
-
-
-
-
-
PDL BioPharma Reports 2019 Fourth Quarter and Full Year Financial Results and Announces Plan to Dissolve the Company by Year-End 2020
-
-
-
-
-
-
-
Factors of Influence in 2018, Key Indicators and Opportunity within Tegna, Inpixon, Honeywell International, Nektar, PDL Biopharma, and Innoviva – New Research Emphasizes Economic Growth
-
-
-
-
-
-
-
PDL BioPharma Announces Third Quarter 2016 Financial Results
-
-
-
-
-
-
-
PDL BioPharma Announces 2016 Second Quarter Dividend
-
-
-
-
-
-
-
Dr. Samuel Saks Joins PDL BioPharma's Board of Directors
-
-
-
-
-
-
-
Notable 52-Week Highs and Lows 2/24: (HD) (APRI) (COT) High; (DAKT) (PDLI) (FUEL) Low
-
-
-
-
-
-
-
PDL BioPharma, Inc. (PDLI) Declares $0.15 Quarterly Dividend; 8.9% Yield
-
445,353 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

